Jan 26 (Reuters) - Regeneron Pharmaceuticals on Monday said U.S. health regulators accepted its application to review a potent cholesterol drug on a priority basis, potentially
Jan 9 (Reuters) - An experimental drug from Sanofi SA and Regeneron Pharmaceuticals was found to be effective in lowering "bad" cholesterol even when administered once every four weeks, instead of every two weeks.
Holdings [ CPA ] is attractive for a rebound play. Strong large-cap performers with significant insider activity include KMI, REGN , RSG, VRX, CHTR, DVA, TWX . For the week , DJIA -1.22% , SP500 -1.46% , Nasdaq Comp -1.67% , Russell 2000
Stefan Quenneville: Regeneron ( REGN ) is a biotechnology company that we rate as having a narrow moat and a positive moat trend. We think its positive moat trend
Can anyone provide some insight on why they think this company would be a Great Investment? Thank you for the input!
Some of his biggest winners in recent years are shares he bought years ago when they were much smaller, including Regeneron REGN and Salesforce.com CRM. Wymer has beaten large-growth peers during his tenure, albeit with greater volatility. Wymer doesn
relative to sectors such as IT that require lesser capex. Some highflyers sank last week, e.g. biotechs [ ALXN, CELG, GILD, REGN ] and other momentum favorites [ GMCR, FB, TWTR, P, YELP, NFLX, BIDU ]; fears of higher rates and weaker economy were
Isaly , the manager of Eaton Vance health sciences ETHSX . He still likes biotechs and pharma. His picks are AGN, ESRX, ISRG, REGN , RHHBY ; also mentioned are BIIB, GILD, PCYC, MDVN, ALPMY, ABBV, JAZZ, PRGO, ACT, JNJ, BMY, MRK, A . Pg 30: Electronic
(Reuters) - The Food and Drug Administration has asked Regeneron Pharmaceuticals Inc and Sanofi SA to assess potential neurocognitive side effects of their experimental cholesterol drug, Sanofi said...
(Reuters) - Regeneron Pharmaceuticals Inc forecast U.S. sales of eye drug Eylea to reach $1.7-$1.8 billion in 2014 as it expects the drug to win approval for newer uses, sending its shares up 3...